Rahima Jamal
Impact in
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers
- Cutaneous Melanoma Detection and Management
- CAR-T cell therapy research
- Immunology top 5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
- Oncology 15
- Cancer Immunotherapy and Biomarkers 12
- Cutaneous Melanoma Detection and Management 3
- CAR-T cell therapy research 3
-
- Clostridium difficile and Clostridium perfringens research 3
- COVID-19 Clinical Research Studies 1
- Co-authors
- Meriem Messaoudene (2 shared papers)Wilson H. Miller (4 shared papers)Karl Bélanger (3 shared papers)Philip W. Wong (2 shared papers)Arielle Elkrief (2 shared papers)Bertrand Routy (2 shared papers)Corentin Richard (1 shared paper)Nathalie Letarte (1 shared paper)
- Journals
- European Journal of Cancer (5 papers)The Lancet Oncology (4 papers)Journal of Clinical Oncology (2 papers)Nature Medicine (2 papers)OncoImmunology (2 papers)
- Partner nations
- CanadaUnited StatesBelgium
In The Last Decade
Rahima Jamal
35 papers receiving 4.1k citations
Rahima Jamal's Hit Papers
Peers
Comparison fields: 5 of 95
- Oncology 2.7k
- Immunology 828
- Molecular Biology 1.2k
- Infectious Diseases 255
- Cancer Research 166
Countries citing papers authored by Rahima Jamal
This map shows the geographic impact of Rahima Jamal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rahima Jamal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rahima Jamal more than expected).
Fields of papers citing papers by Rahima Jamal
This network shows the impact of papers produced by Rahima Jamal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rahima Jamal. The network helps show where Rahima Jamal may publish in the future.
Co-authors
The 25 scholars most cited alongside Rahima Jamal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma Hit paper breakdown → | 2018 | 1503 |
| 2 | Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial Hit paper breakdown → | 2023 | 378 |
| 3 | 2020 | 354 | |
| 4 | Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial Hit paper breakdown → | 2021 | 296 |
| 5 | Longer Follow-Up Confirms Recurrence-Free Survival Benefit of Adjuvant Pembrolizumab in High-Risk Stage III Melanoma: Updated Results From the EORTC 1325-MG/KEYNOTE-054 Trial Hit paper breakdown → | 2020 | 237 |
| 6 | 2021 | 195 | |
| 7 | 2018 | 181 | |
| 8 | 2019 | 169 | |
| 9 | 2022 | 111 | |
| 10 | 2022 | 106 | |
| 11 | 2022 | 100 | |
| 12 | 2019 | 81 | |
| 13 | 2019 | 61 | |
| 14 | 2021 | 57 | |
| 15 | 2022 | 45 | |
| 16 | 2024 | 45 | |
| 17 | 2019 | 44 | |
| 18 | 2017 | 43 | |
| 19 | 2022 | 25 | |
| 20 | 2023 | 22 |
About Rahima Jamal
Rahima Jamal is a scholar working on Oncology, Infectious Diseases, Immunology, Molecular Biology and Otorhinolaryngology, having authored 35 papers that have together received 4.2k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (12 papers), Cutaneous Melanoma Detection and Management (3 papers), CAR-T cell therapy research (3 papers), Melanoma and MAPK Pathways (3 papers), Clostridium difficile and Clostridium perfringens research (3 papers), Immunotherapy and Immune Responses (2 papers), Gut microbiota and health (2 papers) and COVID-19 Clinical Research Studies (1 paper). The work is most often cited by research in Oncology (2.7k citations), Immunology (828 citations), Molecular Biology (1.2k citations), Infectious Diseases (255 citations) and Cancer Research (166 citations). Rahima Jamal has collaborated with scholars based in Canada, United States and Belgium. Frequent co-authors include Meriem Messaoudene, Wilson H. Miller, Karl Bélanger, Philip W. Wong, Arielle Elkrief, Bertrand Routy, Corentin Richard, Nathalie Letarte, Wiam Belkaïd and Julie Malo. Their work appears in journals such as European Journal of Cancer, The Lancet Oncology, Journal of Clinical Oncology, Nature Medicine and OncoImmunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.